18 February 2019 Comment
Globally, there are 633 marketed products for allergic conjunctivitis.
15 January 2019 Comment
Despite positive data observed with Catalyst Pharmaceuticals’ Firdapse in a proof-of-concept investigator-sponsored trial in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG), the results’ clinical relevance is hard to determine.
18 December 2018 Comment
Chimerix’s oral CMX001 (brincidofovir) may increase the risk of diarrhoea for paediatric patients with adenovirus after allogeneic hematopoietic cell transplant (HCT), although a positive Phase II trial outcome is ultimately expected.
11 December 2018 Comment
The Ebola outbreak that began in August in the Democratic Republic of Congo (DRC) has now reached over 400 cases, becoming the second largest outbreak in history according to the...
3 December 2018 News
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.
21 November 2018 News
Sobi and Novimmune have secured approval from the US Food and Drug Administration (FDA) for Gamifant (emapalumab-lzsg), the first and only treatment indicated for Primary Hemophagocytic Lymphohistiocytosis (HLH).
20 November 2018 Deal News
Iceland-based Alvotech has signed a deal for commercialisation of its biosimilar portfolio in Japan in an exclusive partnership agreement with Fuji Pharma.
29 June 2018 projects
Boehringer Ingelheim is developing a new biologicals development centre (BDC) within its Biberach plant site in Germany.